Form 4: Cumberland Pharmaceuticals Executive Acquires Options in Company Stock
SEC Form 4 Filing
Todd M. Anthony, Vice President of Organizational Development at Cumberland Pharmaceuticals, reports the acquisition of options to purchase 3,000 shares of company stock.
Summary
- On March 17, 2025, Todd M. Anthony, Vice President of Organizational Development at Cumberland Pharmaceuticals Inc. (CPIX), acquired options to purchase 3,000 shares of common stock.
- The exercise price of these options is $5.17 per share.
- The options become exercisable on March 17, 2029, and expire on March 17, 2035.
- Following this transaction, Mr. Anthony directly owns 18,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider transactions.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment between management's interests and shareholder value.
Stakeholder Impact
- Shareholders may view this transaction as a sign of confidence from the executive, as it indicates an investment in the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction: Todd M. Anthony acquired options. |
| 03/17/2029 | Options become exercisable. |
| 03/17/2035 | Options expiration date. |
| 03/18/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.